Pt came to er with fall from electrical post nd sustained injury right foot nd ankle open injury right medial malleous deformity+
Gustilo-Anderson Type IIIA or IIIB
| Type | Criteria |
|---|---|
| IIIA | High energy, >10 cm, adequate soft tissue coverage possible |
| IIIB | Periosteal stripping, bone exposure, requires flap coverage |
| IIIC | Arterial injury requiring repair |
| Priority | Action |
|---|---|
| Now | IV antibiotics (Cefazolin + Tobramycin), tetanus, NV check, moist dressing, splint, X-ray |
| Urgent (<6h) | Ortho consult, CT ankle, OR booking |
| Operative | I&D + temporary external fixation ± staged ORIF |
| Within 7 days | Definitive soft tissue coverage |
Diag-
| View | What to assess |
|---|---|
| AP ankle | Medial malleolus fracture pattern, medial clear space (normal ≤4 mm), tibiofibular overlap |
| Mortise view (15° internal rotation) | Talar shift within mortise, symmetry of joint space around talus, lateral malleolus at level of syndesmosis |
| Lateral ankle | Posterior malleolus fragment, sagittal talar alignment, posterior tibial plafond |
| Test | Purpose |
|---|---|
| FBC (CBC) | Baseline Hb, assess blood loss; WBC for infection baseline |
| Coagulation (PT/INR, aPTT) | Pre-op requirement |
| Blood group & crossmatch | Anticipate surgical blood loss |
| Serum electrolytes (Na, K, Cl, HCO3) | Electrolyte disturbance; acidosis |
| Urea & Creatinine | Renal function baseline |
| Blood glucose | Diabetic status affects healing |
| LFTs | Pre-anaesthetic baseline |
| Test | Purpose | Action Threshold |
|---|---|---|
| Serum CK (Creatine Kinase) | Rhabdomyolysis from muscle destruction | CK >5000 U/L = aggressive IVF |
| Urinalysis + urine myoglobin | Myoglobinuria → acute tubular necrosis | Dark/cola urine = renal risk |
| Serial CK at 6h | CK peaks 24-72h after electrical injury; single value insufficient | Trend matters |
| ECG (12-lead) | Arrhythmia, conduction defects from electrical injury | Any arrhythmia → cardiac monitoring |
| Serum troponin | Myocardial injury from high-voltage current | If ECG abnormal or high-voltage exposure |
| Serum lactate | Tissue perfusion / shock | >2 mmol/L = resuscitate |
| ABG | Metabolic acidosis in crush/electrical injury | |
| Phosphate, uric acid | Markers of cell necrosis |
| Test | Purpose |
|---|---|
| Wound swab | Baseline cultures before IV antibiotics (if time allows - do NOT delay antibiotics for cultures) |
| Tetanus immunisation status | Determine need for toxoid ± TIG |
| CRP, ESR | Baseline inflammatory markers |
| Category | Investigation | Priority |
|---|---|---|
| Imaging | X-ray ankle (AP, mortise, lateral) + foot | Immediate |
| Imaging | CT ankle | Urgent (pre-op) |
| Vascular | Doppler/ABI; CTA if pulse deficit | Immediate |
| Bloods | FBC, coags, U&E, group & save | Immediate |
| Electrical | CK, urine myoglobin, ECG, troponin | Immediate + serial |
| Compartment | Clinical monitoring ± pressure measurement | Ongoing |
| Infection | Wound swab, tetanus status | Before antibiotics if possible |
Should I give trapic soakage is there
tranexamic acid open fracture topical local
tranexamic acid topical wound soakage orthopedic trauma
tranexamic acid trauma hemorrhage fracture systemic IV
tranexamic acid open wound local application bleeding
\"tranexamic acid\" CRASH-3 trauma mortality
| Time from injury | Recommendation |
|---|---|
| <1 hour | Strong benefit - give immediately |
| 1-3 hours | Still beneficial - give ASAP |
| >3 hours | Do NOT give - increases mortality risk |